Breast Cancer Awareness Month: What to Know About Your Risk

October arrives, and with it comes the annual push to talk about breast cancer—the disease that will touch one in eight women at some point in their lives. This year's Breast Cancer Awareness Month lands at a moment when the medical conversation has sharpened around a single, actionable idea: knowing your risk matters, and screening matters more.

The numbers are the starting point. Breast cancer remains one of the most commonly diagnosed cancers among women in the United States, and while survival rates have improved significantly over the past two decades, early detection remains the most reliable lever for better outcomes. A woman diagnosed with breast cancer caught in its earliest stages has substantially different prospects than one whose cancer is found later. The difference between stage one and stage three is not merely statistical—it is the difference between treatment options, between side effects, between years.

Understanding personal risk is where the conversation begins to matter for individuals. Risk is not uniform. Age matters. Family history matters. Certain genetic mutations—BRCA1 and BRCA2 among them—dramatically shift the calculus. Reproductive history, hormone use, alcohol consumption, obesity, and breast density all play roles in determining who faces elevated risk. A woman in her thirties with a mother who had breast cancer at forty-five faces a different equation than a woman with no family history. A woman with dense breast tissue may need different screening protocols than one with average density. The point is not to frighten but to inform: knowing where you sit on the risk spectrum allows you to make decisions about screening frequency and intensity that match your actual situation.

This is where annual screening enters the picture. Medical professionals, including breast surgeons in communities across the country, emphasize that regular mammography—or other imaging appropriate to individual circumstances—catches cancers before they become symptomatic. A woman who finds a lump herself has already waited for her body to announce the problem. A woman screened annually may have her cancer found by a radiologist reading an image, months or years before she would have felt anything. That gap in time can mean the difference between a lumpectomy and a mastectomy, between chemotherapy and radiation alone, between survival rates that hover in the nineties and those that do not.

The World Health Organization and major health agencies have aligned around screening recommendations, though the specifics vary by age and risk profile. For average-risk women, screening typically begins at forty or fifty, depending on the guidelines consulted. For high-risk women—those with genetic predisposition, strong family history, or other factors—screening may begin earlier and occur more frequently. The key is alignment: a woman should know her risk category and should have a clear conversation with her doctor about what screening schedule makes sense for her.

Survival rates have climbed over decades, and screening is a major reason why. A woman diagnosed with breast cancer today has better odds of living five years, ten years, and beyond than a woman diagnosed twenty years ago. Some of that improvement comes from better treatment. Much of it comes from catching cancer earlier, when it is smaller and has not spread. Awareness campaigns like Breast Cancer Awareness Month serve a purpose beyond the symbolic: they prompt women to schedule appointments they might otherwise delay, to have conversations with doctors about risk, to move screening from the category of things they know they should do to things they actually do.

As October unfolds, the message is straightforward and evidence-based. Understand your risk. Talk to your doctor about screening. Get screened according to a schedule that matches your situation. These actions, taken by millions of women, have already shifted the trajectory of breast cancer in this country. The work continues.